There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A 68-year-old woman was admitted in our acute cardiac care unit due to cardiogenic
shock.
The transthoracic echocardiography (TTE) showed severe aortic stenosis, severe left
ventricle (LV) systolic dysfunction (ejection fraction 20%) and a large apical thrombus
(Figure 1A-B). We performed an emergent percutaneous aortic balloon valvuloplasty
(Figure 1C). During the procedure, the coronary
angiography revealed no epicardial coronary disease (Figure 1D). Despite some mild
clinical and hemodynamic improvement (mean
gradient reduced from 40 to 30 mmHg), she remained in New York Heart Association (NYHA)
class IV.
Figure 1
A) Four-chamber view from the admission TTE (arrow: apical thrombus); B)
Colour Doppler showing turbulent flow through the aortic valve in
parasternal long-axis view; C) Percutaneous aortic balloon valvuloplasty; D)
Left coronary angiography; E) TEE showing the large apical thrombus (arrow);
F) Embolic protection system deployment (arrows: filters); G) Angiography
after TAV implantation; H) Embolic filters with particulate debris; I)
Three-chamber view from a TTE, 3-months after the procedure. TTE:
transthoracic echocardiography; TEE: transoesophageal echocardiography; TAV:
transcatheter aortic valve.
The case was discussed by our heart team and she was considered to be at high operative
risk (Society of Thoracic Surgery score 12%; EUROSCORE II 15%). Therefore, we have
decided to implant a transcatheter aortic valve (TAVI) using an embolic protection
system. Aortic annulus sizing was performed intra-procedure using transoesophageal
echocardiography, which also showed the apical thrombus (Figure 1E). Firstly, the
Sentinel Cerebral Protection System (Claret
Medical, Inc) was deployed through right radial access (Figure 1F). Afterwards, a
26 mm Edwards Sapien 3 TAV (Edwards Lifesciences
Corporation) was implanted by transfemoral approach (Figure 1G). The procedure went
without complications and the patient showed
remarkable clinical and hemodynamic improvement, being discharged 11 days after TAVI,
medicated with warfarin. In the one-year follow-up, the patient was in NYHA class
I, TTE
showed normally functioning TAV, improvement of the LV function (40%) and no evidence
of
apical thrombus (Figure 1I).
Publisher:
Sociedade Brasileira de Cardiologia - SBC
ISSN
(Print):
0066-782X
ISSN
(Electronic):
1678-4170
Publication date
(Print and electronic):
November
2017
Publication date
(Print):
November
2017
Volume: 109
Issue: 5
Pages: 495-496
Affiliations
[1
] Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia,
Portugal
[2
] Hospital Divino Espirito Santo, Ponta Delgada, Portugal
Author notes
Mailing Address: João Gonçalves Almeida,
Rua Conceição Fernandes. 4434-502, Vila Nova de Gaia, Portugal.
E-mail:
joaotgalmeida@
123456gmail.com
Article
DOI: 10.5935/abc.20170109
PMC ID: 5729788
SO-VID: 0ccc0b18-34cf-4f73-a86b-b6d165dbbd18
License:
This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.